Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (631-640 of 777) with videos related to

Pageof 78
Sort By:
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
European Radiology|June 13, 2024
Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional strictureSarah Poetter-Lang, Ahmed Ba-Ssalamah, Alina Messner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 9, 2020
Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver diseaseBenedikt Simbrunner, Alexander Stadlmann, Philipp Schwabl, et al.
Scientific Reports|June 14, 2026
Characterization of liver disease regression in murine models of liver fibrosis and portal hypertensionPhilipp Königshofer, Ksenia Brusilovskaya, Benedikt S Hofer, et al.
Hepatology (Baltimore, Md.)|August 13, 2021
Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in miceClaudia D Fuchs, Richard Radun, Emmanuel D Dixon, et al.
Wiener Klinische Wochenschrift|April 13, 2013
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II)Markus Peck-Radosavljevic, Bernhard Angermayr, Christian Datz, et al.
Scientific Reports|July 27, 2025
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis modelsThomas Sorz-Nechay, Ksenia Brusilovskaya, Philipp Königshofer, et al.
Gastroenterology|March 3, 2010
Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitisMarkus Mair, Gernot Zollner, Doris Schneller, et al.
Wiener Klinische Wochenschrift|February 5, 2026
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensationMichael Schwarz, Caroline Schwarz, David J M Bauer, et al.
Pageof 78

Showing results (631-640 of 777) with videos related to

Sort By:
Pageof 78
Journal of Hepatology|January 23, 2022
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLDBernhard Scheiner, Lorenz Balcar, Rosa Johanna Nussbaumer, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
European Radiology|June 13, 2024
Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional strictureSarah Poetter-Lang, Ahmed Ba-Ssalamah, Alina Messner, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 9, 2020
Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver diseaseBenedikt Simbrunner, Alexander Stadlmann, Philipp Schwabl, et al.
Scientific Reports|June 14, 2026
Characterization of liver disease regression in murine models of liver fibrosis and portal hypertensionPhilipp Königshofer, Ksenia Brusilovskaya, Benedikt S Hofer, et al.
Hepatology (Baltimore, Md.)|August 13, 2021
Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in miceClaudia D Fuchs, Richard Radun, Emmanuel D Dixon, et al.
Wiener Klinische Wochenschrift|April 13, 2013
Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II)Markus Peck-Radosavljevic, Bernhard Angermayr, Christian Datz, et al.
Scientific Reports|July 27, 2025
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis modelsThomas Sorz-Nechay, Ksenia Brusilovskaya, Philipp Königshofer, et al.
Gastroenterology|March 3, 2010
Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitisMarkus Mair, Gernot Zollner, Doris Schneller, et al.
Wiener Klinische Wochenschrift|February 5, 2026
Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensationMichael Schwarz, Caroline Schwarz, David J M Bauer, et al.
Pageof 78